About this trial
This is a prospective, multicenter, observational study (mEX-TB study) of patients with extrapulmonary tuberculosis (EPTB). Adult patients newly diagnosed with EPTB will prospectively be enrolled into the study. Clinical data will be collected using standardized questionnaires over the whole treatment period for each individual. Additionally, body fluids (blood, urine) will be collected and stored in a central biobank. Biomarkers in EPTB patients will be analyzed during the course of therapy and correlated with clinical data. In addition, a healthy control group will be added, to be used primarily as technical controls for complex laboratory procedures such as RNA-seq and T-cell based assays.
Eligibility criteria
Qualifiers
Age ≥ 18 years
Isolation of Mycobacterium tuberculosis complex from a bodily secretion or tissue by
PCR
culture or a presumptive clinical diagnosis based on epidemiologic exposure in combination with physical findings, radiographic findings and/or histopathology
Disqualifiers
1. Age <18 years 2. Patient with any social or logistical condition which, as anticipated by the investigator, may interfere with the conduct of the study, such as incapacity to well understand the study content and procedure (in case of any language barriers, a translator may be involved), not willing to collaborate, or anticipated inability to finish study due to physical weakness 3. Dependencies towards the study team (e.g. family members, employees of the same department) 4. Pregnant women 5. Patient in custodianship or guardianship 6. Leading pulmonary manifestation 7. Solitary CNS tuberculosis Patients may take part in other clinical studies and trials, as long as there is no conflict with the inclusion or exclusion criteria of the mEX-TB study and the protocol of the other study or trial does not conflict with the means of data and sample collection and publication of this protocol.
Trial design
Treatments tested in this trial
- biomarker analysis
Treatment groups
Sponsors and collaborators
University of Cologne
Lead sponsor
University Hospital, Bonn
Collaborator
Research Center Borstel
Collaborator
Johann Wolfgang Goethe University Hospital
Collaborator
Universitätsklinikum Hamburg-Eppendorf
Collaborator
University Hospital Heidelberg
Collaborator
Helmholtz Zentrum München
Collaborator
University Hospital of Cologne
Collaborator